Research
Daiwa Securities Upgrades Rohto Pharmaceutical to Outperform from Neutral; Price Target is 2,880 Yen
Rohto Pharmaceutical (TYO:4527) has an average rating of overweight and mean price target of 3,001 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
TYO:4527
